Our Strategy
We believe Harnish Pharma Private Limited is well prepared for a world with a growing, aging population and continuously evolving healthcare needs. We have a clear mission, focused strategy and strong culture, all of which we expect will support the creation of value over the long term for our company and society.
Our strategy is to use science-based innovation to deliver better patient outcomes. We aim to lead in growing areas of healthcare.
Science based Innovation
We believe innovation that produces breakthrough medicines and products will be more important than ever in the healthcare industry in the coming years. We maintain substantial investment in research and development (R&D) aimed at areas of unmet medical needs. Our product pipeline is fed by a distinctive research and clinical approach that focuses on scientific advances before market potential.
Our R&D strategy is to continue reinforcing therapeutic areas where we are already strong – including oncology, cardiovascular, eye care, biosimilars and neuroscience – and to expand into new disease areas that we believe are ripe for innovation, such as immuno-oncology, aging and regenerative medicine, and infectious diseases.
Better patient outcomes
We seek to develop medicines and products that can produce positive real-world outcomes for patients and healthcare providers. The benefits can range from improving the cost-effectiveness of high-quality care to prolonging lives. We are developing services and technologies to augment the benefits of our core products, often in collaboration with healthcare providers and technology companies.
Lead in growing areas of healthcare
We aim to develop innovative products in growing areas of healthcare where we can make a real difference. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Survey No. 2203/1, Village – Dabhala, Gozariya – Visnagar Road,cross,dabhala,gujarat 382865,india
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.harnishpharma.com/
- Keywords
- Manufacturing, Bulk Drug, R & D Center, QC Lab, Formulation, Multi Pallets Capsule, Auto capsule filling machine.
- HQ
- Dabhla, GUJARAT
- Competitors
- MERRIL PHARMA PVT. LTD., Remus Pharmaceuticals Limited, Saga Laboratories (Ahmedabad), Saga Lifesciences Limited, APDM PHARMACEUTICALS PVT. LTD., AMBIX HEALTHCARE LLP, Claroid Pharmaceuticals Pvt Ltd, UNICURE INDIA LTD, Ratnatris Pharmaceuticals, subsidiary of Senores Pharmaceuticals, anetapharma.
Harnish Pharma Pvt. Ltd. Questions
Harnish Pharma Pvt. Ltd.'s website is https://www.harnishpharma.com/
Harnish Pharma Pvt. Ltd.'s LinkedIn profile is https://in.linkedin.com/company/harnish-pharma-pvt-ltd
Harnish Pharma Pvt. Ltd. has
10 employees.
View email and phone details for 10
employees at Harnish Pharma Pvt. Ltd..
Harnish Pharma Pvt. Ltd.'s industry is
Pharmaceutical Manufacturing
Harnish Pharma Pvt. Ltd.'s top competitors are
Merril Pharma Pvt. Ltd.,
Remus Pharmaceuticals Limited,
Saga Laboratories (Ahmedabad),
Saga Lifesciences Limited,
Apdm Pharmaceuticals Pvt. Ltd.,
Ambix Healthcare Llp,
Claroid Pharmaceuticals Pvt Ltd,
Unicure India Ltd,
Ratnatris Pharmaceuticals, Subsidiary Of Senores Pharmaceuticals,
Anetapharma.
Harnish Pharma Pvt. Ltd.'s categories are Pharmaceutical Manufacturing
Harnish Pharma Pvt. Ltd.'s founding year is 2018
